Merck & Co Inc
MRK
Company Profile
Business description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Contact
126 East Lincoln Avenue
RahwayNJ07065
USAT: +1 908 740-4000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
75,000
Stocks News & Analysis
stocks
The 10 best US dividend stocks
These undervalued stocks with reliable dividends are worth considering.
stocks
10 best US blue-chip stocks to buy for the long term
The stocks of these high-quality companies with large market capitalisations look undervalued today.
stocks
The 10 best US dividend stocks
These undervalued stocks with reliable dividends are worth considering.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,195.50 | 10.00 | 0.12% |
| CAC 40 | 7,916.08 | 74.03 | -0.93% |
| DAX 40 | 22,461.52 | 217.22 | -0.96% |
| Dow JONES (US) | 41,583.90 | 715.80 | -1.69% |
| FTSE 100 | 8,658.85 | 7.27 | -0.08% |
| HKSE | 23,426.60 | 152.20 | -0.65% |
| NASDAQ | 17,322.99 | 481.04 | -2.70% |
| Nikkei 225 | 37,120.33 | 679.64 | -1.80% |
| NZX 50 Index | 12,287.46 | 18.33 | -0.15% |
| S&P 500 | 5,580.94 | 112.37 | -1.97% |
| S&P/ASX 200 | 7,982.00 | 13.00 | 0.16% |
| SSE Composite Index | 3,351.31 | 22.44 | -0.67% |